nodes	percent_of_prediction	percent_of_DWPC	metapath
Pirbuterol—ADRB1—obesity	0.258	0.543	CbGaD
Pirbuterol—ADRB2—obesity	0.217	0.457	CbGaD
Pirbuterol—ADRB2—Phenylpropanolamine—obesity	0.179	0.504	CbGbCtD
Pirbuterol—ADRB1—Phenylpropanolamine—obesity	0.176	0.496	CbGbCtD
Pirbuterol—Insomnia—Methamphetamine—obesity	0.000769	0.00734	CcSEcCtD
Pirbuterol—Tension—Phenylpropanolamine—obesity	0.000768	0.00733	CcSEcCtD
Pirbuterol—Nervousness—Phenylpropanolamine—obesity	0.00076	0.00725	CcSEcCtD
Pirbuterol—Contusion—Bupropion—obesity	0.000757	0.00722	CcSEcCtD
Pirbuterol—Insomnia—Benzphetamine—obesity	0.000742	0.00708	CcSEcCtD
Pirbuterol—Tension—Phentermine—obesity	0.000735	0.00701	CcSEcCtD
Pirbuterol—Tremor—Phenylpropanolamine—obesity	0.000733	0.00699	CcSEcCtD
Pirbuterol—Tachycardia—Phendimetrazine—obesity	0.000729	0.00696	CcSEcCtD
Pirbuterol—Nervousness—Phentermine—obesity	0.000727	0.00694	CcSEcCtD
Pirbuterol—Agitation—Phenylpropanolamine—obesity	0.000719	0.00686	CcSEcCtD
Pirbuterol—Glossitis—Bupropion—obesity	0.000716	0.00684	CcSEcCtD
Pirbuterol—Decreased appetite—Benzphetamine—obesity	0.000713	0.0068	CcSEcCtD
Pirbuterol—Anorexia—Phendimetrazine—obesity	0.000712	0.0068	CcSEcCtD
Pirbuterol—Tremor—Phentermine—obesity	0.000701	0.00669	CcSEcCtD
Pirbuterol—Agitation—Phentermine—obesity	0.000688	0.00657	CcSEcCtD
Pirbuterol—Insomnia—Phendimetrazine—obesity	0.000676	0.00645	CcSEcCtD
Pirbuterol—Anxiety—Phenylpropanolamine—obesity	0.000664	0.00633	CcSEcCtD
Pirbuterol—Palpitations—Phentermine—obesity	0.000662	0.00631	CcSEcCtD
Pirbuterol—Alopecia—Diethylpropion—obesity	0.000661	0.00631	CcSEcCtD
Pirbuterol—Hyperkinesia—Sibutramine—obesity	0.000661	0.0063	CcSEcCtD
Pirbuterol—Decreased appetite—Phendimetrazine—obesity	0.00065	0.0062	CcSEcCtD
Pirbuterol—Confusional state—Phenylpropanolamine—obesity	0.000644	0.00614	CcSEcCtD
Pirbuterol—Wheezing—Bupropion—obesity	0.000641	0.00612	CcSEcCtD
Pirbuterol—Tension—Diethylpropion—obesity	0.000639	0.0061	CcSEcCtD
Pirbuterol—Chest pain—Phentermine—obesity	0.000637	0.00608	CcSEcCtD
Pirbuterol—Nervousness—Diethylpropion—obesity	0.000633	0.00604	CcSEcCtD
Pirbuterol—Alopecia—Cimetidine—obesity	0.000629	0.006	CcSEcCtD
Pirbuterol—Dry mouth—Phentermine—obesity	0.000623	0.00595	CcSEcCtD
Pirbuterol—Tachycardia—Phenylpropanolamine—obesity	0.000623	0.00595	CcSEcCtD
Pirbuterol—Oedema—Phentermine—obesity	0.000611	0.00583	CcSEcCtD
Pirbuterol—Nadolol—ADRB3—obesity	0.000611	0.115	CrCbGaD
Pirbuterol—Tremor—Diethylpropion—obesity	0.00061	0.00582	CcSEcCtD
Pirbuterol—Nasal congestion—Sibutramine—obesity	0.000604	0.00576	CcSEcCtD
Pirbuterol—Agitation—Diethylpropion—obesity	0.000598	0.00571	CcSEcCtD
Pirbuterol—Hypotension—Phenylpropanolamine—obesity	0.000597	0.00569	CcSEcCtD
Pirbuterol—Tachycardia—Phentermine—obesity	0.000596	0.00569	CcSEcCtD
Pirbuterol—Abdominal pain—Phendimetrazine—obesity	0.000591	0.00564	CcSEcCtD
Pirbuterol—Clenbuterol—ADRB3—obesity	0.000589	0.111	CrCbGaD
Pirbuterol—Bupranolol—ADRB3—obesity	0.000582	0.11	CrCbGaD
Pirbuterol—Diarrhoea—Methamphetamine—obesity	0.000582	0.00555	CcSEcCtD
Pirbuterol—Insomnia—Phenylpropanolamine—obesity	0.000577	0.00551	CcSEcCtD
Pirbuterol—Hyperkinesia—Bupropion—obesity	0.000576	0.0055	CcSEcCtD
Pirbuterol—Palpitations—Diethylpropion—obesity	0.000576	0.00549	CcSEcCtD
Pirbuterol—Agitation—Cimetidine—obesity	0.000569	0.00543	CcSEcCtD
Pirbuterol—Somnolence—Phenylpropanolamine—obesity	0.000568	0.00542	CcSEcCtD
Pirbuterol—Dizziness—Methamphetamine—obesity	0.000562	0.00537	CcSEcCtD
Pirbuterol—Diarrhoea—Benzphetamine—obesity	0.000561	0.00535	CcSEcCtD
Pirbuterol—Chest pain—Diethylpropion—obesity	0.000554	0.00529	CcSEcCtD
Pirbuterol—Insomnia—Phentermine—obesity	0.000553	0.00527	CcSEcCtD
Pirbuterol—Anxiety—Diethylpropion—obesity	0.000553	0.00527	CcSEcCtD
Pirbuterol—Dizziness—Benzphetamine—obesity	0.000542	0.00517	CcSEcCtD
Pirbuterol—Dry mouth—Diethylpropion—obesity	0.000542	0.00517	CcSEcCtD
Pirbuterol—Migraine—Sibutramine—obesity	0.000541	0.00516	CcSEcCtD
Pirbuterol—Headache—Methamphetamine—obesity	0.000533	0.00508	CcSEcCtD
Pirbuterol—Fatigue—Phentermine—obesity	0.000527	0.00503	CcSEcCtD
Pirbuterol—Nasal congestion—Bupropion—obesity	0.000526	0.00502	CcSEcCtD
Pirbuterol—Feeling abnormal—Phenylpropanolamine—obesity	0.000526	0.00502	CcSEcCtD
Pirbuterol—Anxiety—Cimetidine—obesity	0.000526	0.00502	CcSEcCtD
Pirbuterol—Tachycardia—Diethylpropion—obesity	0.000519	0.00495	CcSEcCtD
Pirbuterol—Headache—Benzphetamine—obesity	0.000514	0.0049	CcSEcCtD
Pirbuterol—Cramp muscle—Orlistat—obesity	0.000512	0.00488	CcSEcCtD
Pirbuterol—Diarrhoea—Phendimetrazine—obesity	0.000511	0.00488	CcSEcCtD
Pirbuterol—Dysphonia—Topiramate—obesity	0.000511	0.00488	CcSEcCtD
Pirbuterol—Confusional state—Cimetidine—obesity	0.00051	0.00487	CcSEcCtD
Pirbuterol—Dizziness—Phendimetrazine—obesity	0.000494	0.00472	CcSEcCtD
Pirbuterol—Tachycardia—Cimetidine—obesity	0.000494	0.00471	CcSEcCtD
Pirbuterol—Nausea—Benzphetamine—obesity	0.000487	0.00465	CcSEcCtD
Pirbuterol—Sensory loss—Topiramate—obesity	0.000486	0.00463	CcSEcCtD
Pirbuterol—Abdominal pain—Phentermine—obesity	0.000483	0.00461	CcSEcCtD
Pirbuterol—Insomnia—Diethylpropion—obesity	0.000481	0.00459	CcSEcCtD
Pirbuterol—Somnolence—Diethylpropion—obesity	0.000473	0.00451	CcSEcCtD
Pirbuterol—Migraine—Bupropion—obesity	0.000472	0.0045	CcSEcCtD
Pirbuterol—Headache—Phendimetrazine—obesity	0.000468	0.00447	CcSEcCtD
Pirbuterol—Glossitis—Topiramate—obesity	0.000456	0.00436	CcSEcCtD
Pirbuterol—Somnolence—Cimetidine—obesity	0.00045	0.00429	CcSEcCtD
Pirbuterol—Nausea—Phendimetrazine—obesity	0.000444	0.00424	CcSEcCtD
Pirbuterol—Asthenia—Phentermine—obesity	0.000438	0.00418	CcSEcCtD
Pirbuterol—Feeling abnormal—Diethylpropion—obesity	0.000438	0.00418	CcSEcCtD
Pirbuterol—Fatigue—Cimetidine—obesity	0.000436	0.00416	CcSEcCtD
Pirbuterol—Weight increased—Sibutramine—obesity	0.000432	0.00413	CcSEcCtD
Pirbuterol—Cramp muscle—Bupropion—obesity	0.000432	0.00412	CcSEcCtD
Pirbuterol—Dizziness—Phenylpropanolamine—obesity	0.000422	0.00403	CcSEcCtD
Pirbuterol—Diarrhoea—Phentermine—obesity	0.000418	0.00399	CcSEcCtD
Pirbuterol—Feeling abnormal—Cimetidine—obesity	0.000417	0.00398	CcSEcCtD
Pirbuterol—Stomatitis—Sibutramine—obesity	0.000413	0.00394	CcSEcCtD
Pirbuterol—Vomiting—Phenylpropanolamine—obesity	0.000406	0.00387	CcSEcCtD
Pirbuterol—Dizziness—Phentermine—obesity	0.000404	0.00386	CcSEcCtD
Pirbuterol—Rash—Phenylpropanolamine—obesity	0.000403	0.00384	CcSEcCtD
Pirbuterol—Dermatitis—Phenylpropanolamine—obesity	0.000402	0.00384	CcSEcCtD
Pirbuterol—Vomiting—Phentermine—obesity	0.000388	0.00371	CcSEcCtD
Pirbuterol—Rash—Phentermine—obesity	0.000385	0.00368	CcSEcCtD
Pirbuterol—Dermatitis—Phentermine—obesity	0.000385	0.00367	CcSEcCtD
Pirbuterol—Headache—Phentermine—obesity	0.000383	0.00365	CcSEcCtD
Pirbuterol—Nausea—Phenylpropanolamine—obesity	0.000379	0.00362	CcSEcCtD
Pirbuterol—Hypoaesthesia—Sibutramine—obesity	0.000378	0.00361	CcSEcCtD
Pirbuterol—Weight increased—Bupropion—obesity	0.000377	0.0036	CcSEcCtD
Pirbuterol—Hyperkinesia—Topiramate—obesity	0.000367	0.0035	CcSEcCtD
Pirbuterol—Diarrhoea—Diethylpropion—obesity	0.000364	0.00347	CcSEcCtD
Pirbuterol—Nausea—Phentermine—obesity	0.000363	0.00346	CcSEcCtD
Pirbuterol—Asthenia—Cimetidine—obesity	0.000363	0.00346	CcSEcCtD
Pirbuterol—Stomatitis—Bupropion—obesity	0.00036	0.00344	CcSEcCtD
Pirbuterol—Dizziness—Diethylpropion—obesity	0.000351	0.00335	CcSEcCtD
Pirbuterol—Alopecia—Orlistat—obesity	0.000347	0.00331	CcSEcCtD
Pirbuterol—Diarrhoea—Cimetidine—obesity	0.000346	0.0033	CcSEcCtD
Pirbuterol—Vomiting—Diethylpropion—obesity	0.000338	0.00323	CcSEcCtD
Pirbuterol—Alopecia—Sibutramine—obesity	0.000336	0.00321	CcSEcCtD
Pirbuterol—Nasal congestion—Topiramate—obesity	0.000335	0.0032	CcSEcCtD
Pirbuterol—Rash—Diethylpropion—obesity	0.000335	0.0032	CcSEcCtD
Pirbuterol—Dermatitis—Diethylpropion—obesity	0.000335	0.0032	CcSEcCtD
Pirbuterol—Dizziness—Cimetidine—obesity	0.000334	0.00319	CcSEcCtD
Pirbuterol—Headache—Diethylpropion—obesity	0.000333	0.00318	CcSEcCtD
Pirbuterol—Back pain—Orlistat—obesity	0.000331	0.00316	CcSEcCtD
Pirbuterol—Hypoaesthesia—Bupropion—obesity	0.00033	0.00315	CcSEcCtD
Pirbuterol—Muscle spasms—Orlistat—obesity	0.000329	0.00314	CcSEcCtD
Pirbuterol—Terbutaline—BCHE—obesity	0.000326	0.0617	CrCbGaD
Pirbuterol—Tension—Sibutramine—obesity	0.000325	0.0031	CcSEcCtD
Pirbuterol—Nervousness—Sibutramine—obesity	0.000322	0.00307	CcSEcCtD
Pirbuterol—Vomiting—Cimetidine—obesity	0.000322	0.00307	CcSEcCtD
Pirbuterol—Back pain—Sibutramine—obesity	0.00032	0.00306	CcSEcCtD
Pirbuterol—Rash—Cimetidine—obesity	0.000319	0.00304	CcSEcCtD
Pirbuterol—Dermatitis—Cimetidine—obesity	0.000319	0.00304	CcSEcCtD
Pirbuterol—Muscle spasms—Sibutramine—obesity	0.000318	0.00304	CcSEcCtD
Pirbuterol—Headache—Cimetidine—obesity	0.000317	0.00302	CcSEcCtD
Pirbuterol—Nausea—Diethylpropion—obesity	0.000316	0.00301	CcSEcCtD
Pirbuterol—Tremor—Sibutramine—obesity	0.00031	0.00296	CcSEcCtD
Pirbuterol—Flushing—Bupropion—obesity	0.000308	0.00294	CcSEcCtD
Pirbuterol—Agitation—Sibutramine—obesity	0.000304	0.0029	CcSEcCtD
Pirbuterol—Palpitations—Orlistat—obesity	0.000302	0.00289	CcSEcCtD
Pirbuterol—Migraine—Topiramate—obesity	0.000301	0.00287	CcSEcCtD
Pirbuterol—Nausea—Cimetidine—obesity	0.0003	0.00287	CcSEcCtD
Pirbuterol—Cough—Orlistat—obesity	0.000299	0.00285	CcSEcCtD
Pirbuterol—Syncope—Sibutramine—obesity	0.000297	0.00283	CcSEcCtD
Pirbuterol—Alopecia—Bupropion—obesity	0.000293	0.0028	CcSEcCtD
Pirbuterol—Palpitations—Sibutramine—obesity	0.000293	0.00279	CcSEcCtD
Pirbuterol—Chest pain—Orlistat—obesity	0.000291	0.00278	CcSEcCtD
Pirbuterol—Loss of consciousness—Sibutramine—obesity	0.000291	0.00278	CcSEcCtD
Pirbuterol—Anxiety—Orlistat—obesity	0.00029	0.00277	CcSEcCtD
Pirbuterol—Cough—Sibutramine—obesity	0.000289	0.00276	CcSEcCtD
Pirbuterol—Dry mouth—Orlistat—obesity	0.000285	0.00272	CcSEcCtD
Pirbuterol—Tension—Bupropion—obesity	0.000283	0.0027	CcSEcCtD
Pirbuterol—Chest pain—Sibutramine—obesity	0.000282	0.00269	CcSEcCtD
Pirbuterol—Anxiety—Sibutramine—obesity	0.000281	0.00268	CcSEcCtD
Pirbuterol—Nervousness—Bupropion—obesity	0.00028	0.00268	CcSEcCtD
Pirbuterol—Terbutaline—ADRB2—obesity	0.00028	0.053	CrCbGaD
Pirbuterol—Oedema—Orlistat—obesity	0.000279	0.00266	CcSEcCtD
Pirbuterol—Back pain—Bupropion—obesity	0.000279	0.00266	CcSEcCtD
Pirbuterol—Muscle spasms—Bupropion—obesity	0.000278	0.00265	CcSEcCtD
Pirbuterol—Nadolol—ADRB1—obesity	0.000276	0.0522	CrCbGaD
Pirbuterol—Dry mouth—Sibutramine—obesity	0.000276	0.00263	CcSEcCtD
Pirbuterol—Confusional state—Sibutramine—obesity	0.000272	0.0026	CcSEcCtD
Pirbuterol—Tremor—Bupropion—obesity	0.00027	0.00258	CcSEcCtD
Pirbuterol—Oedema—Sibutramine—obesity	0.00027	0.00258	CcSEcCtD
Pirbuterol—Clenbuterol—ADRB1—obesity	0.000266	0.0504	CrCbGaD
Pirbuterol—Shock—Sibutramine—obesity	0.000266	0.00254	CcSEcCtD
Pirbuterol—Agitation—Bupropion—obesity	0.000265	0.00253	CcSEcCtD
Pirbuterol—Tachycardia—Sibutramine—obesity	0.000264	0.00252	CcSEcCtD
Pirbuterol—Bupranolol—ADRB1—obesity	0.000263	0.0498	CrCbGaD
Pirbuterol—Syncope—Bupropion—obesity	0.000259	0.00247	CcSEcCtD
Pirbuterol—Anorexia—Sibutramine—obesity	0.000258	0.00246	CcSEcCtD
Pirbuterol—Palpitations—Bupropion—obesity	0.000255	0.00243	CcSEcCtD
Pirbuterol—Loss of consciousness—Bupropion—obesity	0.000254	0.00242	CcSEcCtD
Pirbuterol—Clenbuterol—TNF—obesity	0.000253	0.0478	CrCbGaD
Pirbuterol—Insomnia—Orlistat—obesity	0.000253	0.00241	CcSEcCtD
Pirbuterol—Hypotension—Sibutramine—obesity	0.000252	0.00241	CcSEcCtD
Pirbuterol—Cough—Bupropion—obesity	0.000252	0.0024	CcSEcCtD
Pirbuterol—Salbutamol—ADRB1—obesity	0.000248	0.0468	CrCbGaD
Pirbuterol—Epinephrine—ADRB3—obesity	0.000247	0.0468	CrCbGaD
Pirbuterol—Chest pain—Bupropion—obesity	0.000246	0.00235	CcSEcCtD
Pirbuterol—Anxiety—Bupropion—obesity	0.000245	0.00234	CcSEcCtD
Pirbuterol—Insomnia—Sibutramine—obesity	0.000244	0.00233	CcSEcCtD
Pirbuterol—Decreased appetite—Orlistat—obesity	0.000243	0.00232	CcSEcCtD
Pirbuterol—Fatigue—Orlistat—obesity	0.000241	0.0023	CcSEcCtD
Pirbuterol—Dry mouth—Bupropion—obesity	0.00024	0.00229	CcSEcCtD
Pirbuterol—Somnolence—Sibutramine—obesity	0.00024	0.00229	CcSEcCtD
Pirbuterol—Weight increased—Topiramate—obesity	0.00024	0.00229	CcSEcCtD
Pirbuterol—Confusional state—Bupropion—obesity	0.000238	0.00227	CcSEcCtD
Pirbuterol—Oedema—Bupropion—obesity	0.000236	0.00225	CcSEcCtD
Pirbuterol—Decreased appetite—Sibutramine—obesity	0.000235	0.00224	CcSEcCtD
Pirbuterol—Nadolol—ADRB2—obesity	0.000232	0.0439	CrCbGaD
Pirbuterol—Shock—Bupropion—obesity	0.000232	0.00221	CcSEcCtD
Pirbuterol—Feeling abnormal—Orlistat—obesity	0.00023	0.0022	CcSEcCtD
Pirbuterol—Tachycardia—Bupropion—obesity	0.00023	0.00219	CcSEcCtD
Pirbuterol—Stomatitis—Topiramate—obesity	0.000229	0.00219	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Orlistat—obesity	0.000228	0.00218	CcSEcCtD
Pirbuterol—Anorexia—Bupropion—obesity	0.000225	0.00214	CcSEcCtD
Pirbuterol—Clenbuterol—ADRB2—obesity	0.000224	0.0424	CrCbGaD
Pirbuterol—Feeling abnormal—Sibutramine—obesity	0.000223	0.00213	CcSEcCtD
Pirbuterol—Bupranolol—ADRB2—obesity	0.000221	0.0419	CrCbGaD
Pirbuterol—Gastrointestinal pain—Sibutramine—obesity	0.000221	0.00211	CcSEcCtD
Pirbuterol—Abdominal pain—Orlistat—obesity	0.000221	0.00211	CcSEcCtD
Pirbuterol—Hypotension—Bupropion—obesity	0.00022	0.0021	CcSEcCtD
Pirbuterol—Abdominal pain—Sibutramine—obesity	0.000214	0.00204	CcSEcCtD
Pirbuterol—Insomnia—Bupropion—obesity	0.000213	0.00203	CcSEcCtD
Pirbuterol—Hypoaesthesia—Topiramate—obesity	0.00021	0.00201	CcSEcCtD
Pirbuterol—Somnolence—Bupropion—obesity	0.000209	0.002	CcSEcCtD
Pirbuterol—Salbutamol—ADRB2—obesity	0.000208	0.0394	CrCbGaD
Pirbuterol—Decreased appetite—Bupropion—obesity	0.000205	0.00195	CcSEcCtD
Pirbuterol—Fatigue—Bupropion—obesity	0.000203	0.00194	CcSEcCtD
Pirbuterol—Asthenia—Orlistat—obesity	0.0002	0.00191	CcSEcCtD
Pirbuterol—Pruritus—Orlistat—obesity	0.000198	0.00189	CcSEcCtD
Pirbuterol—Flushing—Topiramate—obesity	0.000196	0.00187	CcSEcCtD
Pirbuterol—Feeling abnormal—Bupropion—obesity	0.000194	0.00185	CcSEcCtD
Pirbuterol—Asthenia—Sibutramine—obesity	0.000194	0.00185	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Bupropion—obesity	0.000193	0.00184	CcSEcCtD
Pirbuterol—Pruritus—Sibutramine—obesity	0.000191	0.00182	CcSEcCtD
Pirbuterol—Diarrhoea—Orlistat—obesity	0.000191	0.00182	CcSEcCtD
Pirbuterol—Alopecia—Topiramate—obesity	0.000187	0.00178	CcSEcCtD
Pirbuterol—Abdominal pain—Bupropion—obesity	0.000186	0.00178	CcSEcCtD
Pirbuterol—Diarrhoea—Sibutramine—obesity	0.000185	0.00176	CcSEcCtD
Pirbuterol—Dizziness—Orlistat—obesity	0.000185	0.00176	CcSEcCtD
Pirbuterol—Tension—Topiramate—obesity	0.00018	0.00172	CcSEcCtD
Pirbuterol—Dizziness—Sibutramine—obesity	0.000179	0.00171	CcSEcCtD
Pirbuterol—Nervousness—Topiramate—obesity	0.000179	0.0017	CcSEcCtD
Pirbuterol—Back pain—Topiramate—obesity	0.000178	0.0017	CcSEcCtD
Pirbuterol—Vomiting—Orlistat—obesity	0.000178	0.00169	CcSEcCtD
Pirbuterol—Muscle spasms—Topiramate—obesity	0.000177	0.00169	CcSEcCtD
Pirbuterol—Rash—Orlistat—obesity	0.000176	0.00168	CcSEcCtD
Pirbuterol—Dermatitis—Orlistat—obesity	0.000176	0.00168	CcSEcCtD
Pirbuterol—Headache—Orlistat—obesity	0.000175	0.00167	CcSEcCtD
Pirbuterol—Tremor—Topiramate—obesity	0.000172	0.00164	CcSEcCtD
Pirbuterol—Vomiting—Sibutramine—obesity	0.000172	0.00164	CcSEcCtD
Pirbuterol—Rash—Sibutramine—obesity	0.00017	0.00163	CcSEcCtD
Pirbuterol—Dermatitis—Sibutramine—obesity	0.00017	0.00162	CcSEcCtD
Pirbuterol—Headache—Sibutramine—obesity	0.000169	0.00162	CcSEcCtD
Pirbuterol—Asthenia—Bupropion—obesity	0.000169	0.00161	CcSEcCtD
Pirbuterol—Agitation—Topiramate—obesity	0.000169	0.00161	CcSEcCtD
Pirbuterol—Pruritus—Bupropion—obesity	0.000167	0.00159	CcSEcCtD
Pirbuterol—Nausea—Orlistat—obesity	0.000166	0.00158	CcSEcCtD
Pirbuterol—Syncope—Topiramate—obesity	0.000165	0.00157	CcSEcCtD
Pirbuterol—Palpitations—Topiramate—obesity	0.000163	0.00155	CcSEcCtD
Pirbuterol—Loss of consciousness—Topiramate—obesity	0.000162	0.00154	CcSEcCtD
Pirbuterol—Diarrhoea—Bupropion—obesity	0.000161	0.00154	CcSEcCtD
Pirbuterol—Nausea—Sibutramine—obesity	0.000161	0.00153	CcSEcCtD
Pirbuterol—Cough—Topiramate—obesity	0.00016	0.00153	CcSEcCtD
Pirbuterol—Chest pain—Topiramate—obesity	0.000157	0.00149	CcSEcCtD
Pirbuterol—Anxiety—Topiramate—obesity	0.000156	0.00149	CcSEcCtD
Pirbuterol—Dizziness—Bupropion—obesity	0.000156	0.00149	CcSEcCtD
Pirbuterol—Dry mouth—Topiramate—obesity	0.000153	0.00146	CcSEcCtD
Pirbuterol—Confusional state—Topiramate—obesity	0.000151	0.00144	CcSEcCtD
Pirbuterol—Oedema—Topiramate—obesity	0.00015	0.00143	CcSEcCtD
Pirbuterol—Vomiting—Bupropion—obesity	0.00015	0.00143	CcSEcCtD
Pirbuterol—Rash—Bupropion—obesity	0.000149	0.00142	CcSEcCtD
Pirbuterol—Dermatitis—Bupropion—obesity	0.000148	0.00142	CcSEcCtD
Pirbuterol—Shock—Topiramate—obesity	0.000148	0.00141	CcSEcCtD
Pirbuterol—Headache—Bupropion—obesity	0.000148	0.00141	CcSEcCtD
Pirbuterol—Epinephrine—SLC22A1—obesity	0.000147	0.0279	CrCbGaD
Pirbuterol—Tachycardia—Topiramate—obesity	0.000146	0.0014	CcSEcCtD
Pirbuterol—Anorexia—Topiramate—obesity	0.000143	0.00137	CcSEcCtD
Pirbuterol—Hypotension—Topiramate—obesity	0.00014	0.00134	CcSEcCtD
Pirbuterol—Nausea—Bupropion—obesity	0.00014	0.00134	CcSEcCtD
Pirbuterol—Insomnia—Topiramate—obesity	0.000136	0.0013	CcSEcCtD
Pirbuterol—Somnolence—Topiramate—obesity	0.000133	0.00127	CcSEcCtD
Pirbuterol—Decreased appetite—Topiramate—obesity	0.00013	0.00125	CcSEcCtD
Pirbuterol—Fatigue—Topiramate—obesity	0.000129	0.00123	CcSEcCtD
Pirbuterol—Feeling abnormal—Topiramate—obesity	0.000124	0.00118	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Topiramate—obesity	0.000123	0.00117	CcSEcCtD
Pirbuterol—Abdominal pain—Topiramate—obesity	0.000119	0.00113	CcSEcCtD
Pirbuterol—Epinephrine—ADRB1—obesity	0.000112	0.0212	CrCbGaD
Pirbuterol—Asthenia—Topiramate—obesity	0.000108	0.00103	CcSEcCtD
Pirbuterol—Pruritus—Topiramate—obesity	0.000106	0.00101	CcSEcCtD
Pirbuterol—Epinephrine—TNF—obesity	0.000106	0.0201	CrCbGaD
Pirbuterol—Diarrhoea—Topiramate—obesity	0.000103	0.00098	CcSEcCtD
Pirbuterol—Dizziness—Topiramate—obesity	9.92e-05	0.000947	CcSEcCtD
Pirbuterol—Vomiting—Topiramate—obesity	9.54e-05	0.000911	CcSEcCtD
Pirbuterol—Rash—Topiramate—obesity	9.46e-05	0.000903	CcSEcCtD
Pirbuterol—Dermatitis—Topiramate—obesity	9.45e-05	0.000902	CcSEcCtD
Pirbuterol—Epinephrine—ADRB2—obesity	9.41e-05	0.0178	CrCbGaD
Pirbuterol—Headache—Topiramate—obesity	9.4e-05	0.000897	CcSEcCtD
Pirbuterol—Nausea—Topiramate—obesity	8.91e-05	0.000851	CcSEcCtD
Pirbuterol—ADRB2—Signaling by GPCR—DRD4—obesity	2.31e-05	0.000384	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR ligand binding—CCL2—obesity	2.29e-05	0.000381	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CNR1—obesity	2.25e-05	0.000374	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CNR1—obesity	2.2e-05	0.000366	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—DRD2—obesity	2.2e-05	0.000365	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—GCG—obesity	2.18e-05	0.000362	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—ADRB2—obesity	2.17e-05	0.00036	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—ADRB3—obesity	2.15e-05	0.000358	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—DRD2—obesity	2.15e-05	0.000357	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—GCG—obesity	2.13e-05	0.000354	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—ADRB3—obesity	2.11e-05	0.00035	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—GAL—obesity	2.1e-05	0.00035	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—C5AR1—obesity	2.08e-05	0.000346	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—GNB3—obesity	2.07e-05	0.000343	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—GAL—obesity	2.06e-05	0.000342	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—C5AR1—obesity	2.04e-05	0.000338	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—GNB3—obesity	2.02e-05	0.000336	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—GNAS—obesity	2.01e-05	0.000334	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—ADRB2—obesity	1.97e-05	0.000327	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—GNAS—obesity	1.97e-05	0.000327	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—CCL5—obesity	1.92e-05	0.00032	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CCK—obesity	1.9e-05	0.000316	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PRKG1—obesity	1.9e-05	0.000316	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—CCL5—obesity	1.88e-05	0.000313	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—GNB3—obesity	1.88e-05	0.000312	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CCK—obesity	1.86e-05	0.000309	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PRKG1—obesity	1.86e-05	0.000309	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—RBP4—obesity	1.85e-05	0.000308	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—GLP1R—obesity	1.85e-05	0.000308	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—GNB3—obesity	1.83e-05	0.000305	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—GNAS—obesity	1.83e-05	0.000303	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CCKAR—obesity	1.82e-05	0.000303	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—HRH3—obesity	1.82e-05	0.000303	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—RBP4—obesity	1.81e-05	0.000301	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—GLP1R—obesity	1.81e-05	0.000301	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—GNAS—obesity	1.79e-05	0.000297	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CCKAR—obesity	1.78e-05	0.000297	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—HRH3—obesity	1.78e-05	0.000297	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PRKAR2B—obesity	1.76e-05	0.000292	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CCL5—obesity	1.75e-05	0.00029	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PRKCD—obesity	1.73e-05	0.000288	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PRKAR2B—obesity	1.72e-05	0.000285	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CCL5—obesity	1.71e-05	0.000284	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NCF2—obesity	1.7e-05	0.000282	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—HTR2A—obesity	1.7e-05	0.000282	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PRKCD—obesity	1.69e-05	0.000282	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—C3—obesity	1.69e-05	0.000281	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NCF2—obesity	1.66e-05	0.000276	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—HTR2A—obesity	1.66e-05	0.000276	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—C3—obesity	1.66e-05	0.000275	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NPY—obesity	1.65e-05	0.000275	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—APOC3—obesity	1.64e-05	0.000273	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—IAPP—obesity	1.64e-05	0.000273	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NPY—obesity	1.62e-05	0.000269	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—AGT—obesity	1.61e-05	0.000267	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—IAPP—obesity	1.61e-05	0.000267	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—APOC3—obesity	1.61e-05	0.000267	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—HTR1B—obesity	1.59e-05	0.000265	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CRH—obesity	1.59e-05	0.000265	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—SDC1—obesity	1.58e-05	0.000262	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—AGT—obesity	1.57e-05	0.000261	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PRKCD—obesity	1.57e-05	0.000261	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—HTR1B—obesity	1.56e-05	0.000259	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CRH—obesity	1.56e-05	0.000259	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—AKR1C3—obesity	1.55e-05	0.000258	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—SDC1—obesity	1.54e-05	0.000256	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—HTR2A—obesity	1.54e-05	0.000256	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PRKCD—obesity	1.54e-05	0.000256	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—C3—obesity	1.54e-05	0.000255	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—AKR1C3—obesity	1.52e-05	0.000252	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NPS—obesity	1.51e-05	0.000251	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—HTR2A—obesity	1.51e-05	0.00025	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—C3—obesity	1.5e-05	0.00025	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—F2—obesity	1.49e-05	0.000247	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PRKCB—obesity	1.49e-05	0.000247	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—DRD1—obesity	1.48e-05	0.000246	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—HTR2C—obesity	1.48e-05	0.000246	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NPS—obesity	1.48e-05	0.000246	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—AGT—obesity	1.46e-05	0.000243	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—F2—obesity	1.45e-05	0.000242	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PRKCB—obesity	1.45e-05	0.000242	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—HTR2C—obesity	1.45e-05	0.000241	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—DRD1—obesity	1.45e-05	0.000241	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NTRK2—obesity	1.44e-05	0.00024	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—AGT—obesity	1.43e-05	0.000237	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PIK3CG—obesity	1.42e-05	0.000236	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NTRK2—obesity	1.41e-05	0.000234	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PARP1—obesity	1.41e-05	0.000234	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—GHRL—obesity	1.41e-05	0.000234	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—ADRB1—obesity	1.4e-05	0.000233	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—DRD4—obesity	1.39e-05	0.000232	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PIK3CG—obesity	1.39e-05	0.000231	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PARP1—obesity	1.37e-05	0.000228	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—GHRL—obesity	1.37e-05	0.000228	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—DRD4—obesity	1.36e-05	0.000227	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—POMC—obesity	1.35e-05	0.000225	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PRKCB—obesity	1.35e-05	0.000224	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—F2—obesity	1.35e-05	0.000224	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CNR1—obesity	1.33e-05	0.000221	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—POMC—obesity	1.32e-05	0.00022	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PRKCB—obesity	1.32e-05	0.000219	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—F2—obesity	1.32e-05	0.000219	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—TCF7L2—obesity	1.31e-05	0.000217	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CNR1—obesity	1.3e-05	0.000216	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—AKT2—obesity	1.3e-05	0.000216	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—DRD2—obesity	1.3e-05	0.000216	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PIK3CG—obesity	1.29e-05	0.000215	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—GCG—obesity	1.29e-05	0.000214	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PTPN1—obesity	1.29e-05	0.000214	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—TCF7L2—obesity	1.28e-05	0.000213	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—AKT2—obesity	1.27e-05	0.000212	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—DRD2—obesity	1.27e-05	0.000211	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PIK3CG—obesity	1.26e-05	0.00021	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—GCG—obesity	1.26e-05	0.000209	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PTPN1—obesity	1.26e-05	0.000209	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PIK3CD—obesity	1.25e-05	0.000208	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—POMC—obesity	1.23e-05	0.000204	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PRL—obesity	1.23e-05	0.000204	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PIK3CD—obesity	1.22e-05	0.000203	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—STK11—obesity	1.21e-05	0.000201	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CCL2—obesity	1.2e-05	0.0002	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—POMC—obesity	1.2e-05	0.0002	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PRL—obesity	1.2e-05	0.000199	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PLG—obesity	1.2e-05	0.000199	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—RHOA—obesity	1.19e-05	0.000198	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—STK11—obesity	1.18e-05	0.000196	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—AKT2—obesity	1.18e-05	0.000196	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PIK3R1—obesity	1.18e-05	0.000196	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CCL2—obesity	1.18e-05	0.000196	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PLG—obesity	1.17e-05	0.000194	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—RHOA—obesity	1.17e-05	0.000194	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—FOXO3—obesity	1.17e-05	0.000194	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—ADRB2—obesity	1.16e-05	0.000193	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—AKT2—obesity	1.16e-05	0.000192	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PIK3R1—obesity	1.16e-05	0.000192	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—SOCS1—obesity	1.15e-05	0.00019	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—FOXO3—obesity	1.14e-05	0.00019	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PIK3CD—obesity	1.14e-05	0.000189	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—SOCS3—obesity	1.13e-05	0.000188	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—SOCS1—obesity	1.12e-05	0.000186	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PIK3CD—obesity	1.11e-05	0.000185	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—GNB3—obesity	1.11e-05	0.000184	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—SOCS3—obesity	1.11e-05	0.000184	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—TYK2—obesity	1.09e-05	0.000182	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PIK3CB—obesity	1.09e-05	0.000181	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—IGF2—obesity	1.09e-05	0.000181	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—GNB3—obesity	1.08e-05	0.00018	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—RHOA—obesity	1.08e-05	0.00018	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—GNAS—obesity	1.08e-05	0.000179	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PIK3R1—obesity	1.07e-05	0.000178	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—TYK2—obesity	1.07e-05	0.000178	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PIK3CB—obesity	1.07e-05	0.000177	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—IGF2—obesity	1.06e-05	0.000177	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—RHOA—obesity	1.06e-05	0.000176	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—APOB—obesity	1.06e-05	0.000176	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—GNAS—obesity	1.06e-05	0.000175	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PIK3R1—obesity	1.05e-05	0.000174	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—APOB—obesity	1.03e-05	0.000172	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CCL5—obesity	1.03e-05	0.000171	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CCL5—obesity	1.01e-05	0.000168	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—LPL—obesity	1.01e-05	0.000168	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—FOXO1—obesity	1e-05	0.000166	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—RPS6KB1—obesity	1e-05	0.000166	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PIK3CB—obesity	9.9e-06	0.000164	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—LPL—obesity	9.87e-06	0.000164	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—FOXO1—obesity	9.8e-06	0.000163	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—RPS6KB1—obesity	9.78e-06	0.000163	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PIK3CB—obesity	9.68e-06	0.000161	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PRKCD—obesity	9.29e-06	0.000154	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—HTR2A—obesity	9.1e-06	0.000151	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PRKCD—obesity	9.09e-06	0.000151	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—C3—obesity	9.08e-06	0.000151	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—HTR2A—obesity	8.9e-06	0.000148	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—C3—obesity	8.88e-06	0.000148	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—IRS2—obesity	8.64e-06	0.000144	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—AGT—obesity	8.63e-06	0.000143	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—APOE—obesity	8.46e-06	0.000141	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—LEP—obesity	8.46e-06	0.000141	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—IRS2—obesity	8.45e-06	0.00014	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—AGT—obesity	8.44e-06	0.00014	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CAV1—obesity	8.38e-06	0.000139	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—APOA1—obesity	8.36e-06	0.000139	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—APOE—obesity	8.27e-06	0.000137	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—LEP—obesity	8.27e-06	0.000137	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CAV1—obesity	8.2e-06	0.000136	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—APOA1—obesity	8.18e-06	0.000136	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—ESR1—obesity	8.07e-06	0.000134	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PRKCB—obesity	7.97e-06	0.000133	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—F2—obesity	7.97e-06	0.000133	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—ESR1—obesity	7.9e-06	0.000131	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—BAD—obesity	7.88e-06	0.000131	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—F2—obesity	7.8e-06	0.00013	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PRKCB—obesity	7.8e-06	0.00013	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—BAD—obesity	7.71e-06	0.000128	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PIK3CG—obesity	7.63e-06	0.000127	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—IRS1—obesity	7.54e-06	0.000125	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PIK3CG—obesity	7.46e-06	0.000124	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—IRS1—obesity	7.38e-06	0.000123	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—POMC—obesity	7.26e-06	0.000121	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—INS—obesity	7.22e-06	0.00012	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CCL2—obesity	7.11e-06	0.000118	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—POMC—obesity	7.11e-06	0.000118	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—INS—obesity	7.07e-06	0.000117	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—IGF1—obesity	6.99e-06	0.000116	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—AKT2—obesity	6.98e-06	0.000116	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CCL2—obesity	6.95e-06	0.000116	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—IGF1—obesity	6.83e-06	0.000114	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—AKT2—obesity	6.83e-06	0.000113	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PIK3CD—obesity	6.71e-06	0.000111	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PIK3CA—obesity	6.64e-06	0.00011	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—SERPINE1—obesity	6.64e-06	0.00011	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PIK3CD—obesity	6.56e-06	0.000109	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PIK3CA—obesity	6.5e-06	0.000108	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—SERPINE1—obesity	6.49e-06	0.000108	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—TYK2—obesity	6.45e-06	0.000107	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—RHOA—obesity	6.4e-06	0.000106	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PIK3R1—obesity	6.33e-06	0.000105	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NOS3—obesity	6.33e-06	0.000105	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—TYK2—obesity	6.31e-06	0.000105	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—RHOA—obesity	6.26e-06	0.000104	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NOS3—obesity	6.2e-06	0.000103	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PIK3R1—obesity	6.2e-06	0.000103	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PIK3CA—obesity	6.03e-06	0.0001	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PIK3CA—obesity	5.9e-06	9.81e-05	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PIK3CB—obesity	5.85e-06	9.72e-05	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MTOR—obesity	5.85e-06	9.72e-05	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MTOR—obesity	5.72e-06	9.5e-05	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PIK3CB—obesity	5.72e-06	9.5e-05	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—AKT1—obesity	5.43e-06	9.02e-05	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—IL6—obesity	5.34e-06	8.88e-05	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—AKT1—obesity	5.31e-06	8.82e-05	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—IL6—obesity	5.23e-06	8.69e-05	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MMP9—obesity	5.08e-06	8.45e-05	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MMP9—obesity	4.97e-06	8.26e-05	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MAPK8—obesity	4.94e-06	8.21e-05	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—AKT1—obesity	4.93e-06	8.19e-05	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MAPK8—obesity	4.84e-06	8.03e-05	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—AKT1—obesity	4.82e-06	8.01e-05	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—STAT3—obesity	4.52e-06	7.51e-05	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—STAT3—obesity	4.42e-06	7.35e-05	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MYC—obesity	4.2e-06	6.98e-05	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—TGFB1—obesity	4.19e-06	6.96e-05	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MYC—obesity	4.11e-06	6.83e-05	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—TGFB1—obesity	4.1e-06	6.81e-05	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PIK3CA—obesity	3.56e-06	5.92e-05	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PIK3CA—obesity	3.49e-06	5.79e-05	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—IL6—obesity	3.16e-06	5.24e-05	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—IL6—obesity	3.09e-06	5.13e-05	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—AKT1—obesity	2.91e-06	4.84e-05	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—AKT1—obesity	2.85e-06	4.73e-05	CbGpPWpGaD
